LASP1
LIM and SH3 domain protein 1
Also known as: Lasp-1, LASP1_HUMAN, MLN50
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q14847
- Gene
- LASP1
- Ensembl
- ENSG00000002834
- Chromosome
- 17
- Canonical length
- 261 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Focal adhesion sites,Cytosol
OverviewNCBI Gene
This gene encodes a member of a subfamily of LIM proteins, characterized by a LIM motif and a domain of Src homology region 3, and also a member of the nebulin family of actin-binding proteins. The encoded protein is a cAMP and cGMP dependent signaling protein and binds to the actin cytoskeleton at extensions of the cell membrane. The encoded protein has been linked to metastatic breast cancer, hematopoetic tumors such as B-cell lymphomas, and colorectal cancer. [provided by RefSeq, Oct 2012]
Canonical amino-acid sequenceUniProt
261 residues, UniProt reviewed canonical sequence.
>Q14847|LASP1
1 MNPNCARCGK IVYPTEKVNC LDKFWHKACF HCETCKMTLN MKNYKGYEKK PYCNAHYPKQ
61 SFTMVADTPE NLRLKQQSEL QSQVRYKEEF EKNKGKGFSV VADTPELQRI KKTQDQISNI
121 KYHEEFEKSR MGPSGGEGME PERRDSQDGS SYRRPLEQQQ PHHIPTSAPV YQQPQQQPVA
181 QSYGGYKEPA APVSIQRSAP GGGGKRYRAV YDYSAADEDE VSFQDGDTIV NVQQIDDGWM
241 YGTVERTGDT GMLPANYVEA ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against LASP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 159 nTPM
Expression across tissuesHPA
Tissue
- small intestine: 159 nTPM
- duodenum: 124 nTPM
- bone marrow: 119 nTPM
- stomach: 91 nTPM
- colon: 87 nTPM
- rectum: 87 nTPM
Single-cell type
- late spermatids: 1,082 nCPM
- neutrophils: 421 nCPM
- enterocytes: 344 nCPM
- hepatic stellate cells: 297 nCPM
- foveolar cells: 291 nCPM
- neutrophil progenitors: 253 nCPM
Immune cell
- neutrophil: 67 nTPM
- non-classical monocyte: 42 nTPM
- eosinophil: 35 nTPM
- NK-cell: 34 nTPM
- intermediate monocyte: 33 nTPM
- total PBMC: 33 nTPM
Brain region
- thalamus: 110 nTPM
- midbrain: 101 nTPM
- hypothalamus: 94 nTPM
- amygdala: 94 nTPM
- pons: 91 nTPM
- medulla oblongata: 84 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 2.21
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- actin filament binding
- cadherin binding
- metal ion binding
- monoatomic ion transmembrane transporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Nebulin repeat
- SH3 domain
- Zinc finger, LIM-type
- SH3-like domain superfamily
- LIM domain
- Nebulin repeat
- Variant SH3 domain
- Lasp1, SH3 domain
- LIM and SH3 domain-containing protein
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LASP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LASP1 as an antibody target. Whether an autoantibody or antibody against LASP1 could matter depends on whether native LASP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LASP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LASP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...